Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -350,544 | -261,658 | -190,481 | -84,510 | -285,620 |
| Depreciation Amortization | 1,238 | 784 | 482 | 265 | 2,175 |
| Accounts receivable | 607 | -694 | 3,035 | 4,763 | -3,750 |
| Accounts payable and accrued liabilities | 1,881 | 4,749 | -2,993 | 11,469 | -5,242 |
| Other Working Capital | -51,635 | -43,200 | -19,823 | -18,136 | -1,181 |
| Other Operating Activity | 72,395 | 37,342 | 29,471 | -2,271 | 68,493 |
| Operating Cash Flow | $-326,058 | $-262,677 | $-180,309 | $-88,420 | $-225,125 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -259,083 | -218,330 | -166,944 | -78,048 | -575,624 |
| PPE Investments | -2,559 | -1,577 | -1,263 | -512 | -1,236 |
| Sale Of Investment | 435,723 | 338,320 | 236,775 | 148,141 | 353,088 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -5,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -5,000 |
| Investing Cash Flow | $174,081 | $118,413 | $68,568 | $69,581 | $-228,772 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 95,000 | N/A | 95,000 | N/A | 47,444 |
| Common Stock Issued | 15,389 | 14,635 | 8,222 | 5,678 | 399,536 |
| Other Financing Activity | -140 | 94,860 | -140 | -119 | 0 |
| Financing Cash Flow | $110,249 | $109,495 | $103,082 | $5,559 | $446,980 |
| Beginning Cash Position | 181,741 | 181,741 | 181,741 | 181,741 | 188,658 |
| End Cash Position | 140,013 | 146,972 | 173,082 | 168,461 | 181,741 |
| Net Cash Flow | $-41,728 | $-34,769 | $-8,659 | $-13,280 | $-6,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -326,058 | -262,677 | -180,309 | -88,420 | -225,125 |
| Capital Expenditure | -2,559 | -1,577 | -1,263 | -512 | -1,236 |
| Free Cash Flow | -328,617 | -264,254 | -181,572 | -88,932 | -226,361 |